The Diurnal Rhythm in Natriuretic Peptide Levels
1 other identifier
interventional
42
1 country
1
Brief Summary
The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its temporal relationship with nocturnal blood pressure in obese and African-American individuals as compared with lean and white individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2019
CompletedFirst Posted
Study publicly available on registry
February 7, 2019
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedResults Posted
Study results publicly available
August 31, 2021
CompletedFebruary 5, 2024
January 1, 2024
11 months
February 6, 2019
May 28, 2021
January 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma MRproANP
Assess the diurnal rhythm in circulating MRproANP levels among obese individuals and compared it with lean individuals
About 24 hours on the in-patient study visit day after consuming study meals for 5 days
Secondary Outcomes (1)
Acrophase Difference in Hours Between the MR-proANP and Systolic BP Rhythm
About 24 hours on the in-patient study visit day after consuming study meals for 5 days
Other Outcomes (1)
Plasma MRproANP
About 24 hours on the in-patient study visit day after consuming study meals for 5 days
Study Arms (1)
Study Individuals
OTHERHealthy self-identified African-American and white male participants will be screened. Study consent will be obtained, medical history and physical examination administered, and study eligibility determined based on the inclusion and exclusion criteria. Eligible subjects will meet a bio-nutritionist who will explain the 5 days of standardized diet at the screening visit and will review instructions for complying with the diet. If the subject agrees to adhere to the study diet, they will then be enrolled in the study (stratified by race).
Interventions
Standardized diet consisted with eucaloric meals with 4.5 gm of sodium per day for 5 days.
Eligibility Criteria
You may qualify if:
- Age 18 to 40 years
- Blood pressure less than 140/90
- Body Mass Index between 18.5 to 25 kg/m2 (lean) or 30 to 45 kg/m2 (obese)
- Self identified African-American or white individuals
- Willingness to comply with the study diet
- Provide informed consent
You may not qualify if:
- History of hypertension
- History of cardiovascular, renal, or liver disease
- Diabetes or use of glucose-lowering medications
- Use of vasoactive or diuretic medications
- Atrial fibrillation
- Anemia (Hematocrit \<41%)
- Abnormal serum sodium or potassium
- Abnormal liver function tests (\>3x upper limit of normal)
- Current smokers
- Regular users of non-steroid anti-inflammatory medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Related Publications (5)
Goetze JP, Jorgensen HL, Sennels HP, Fahrenkrug J. Diurnal plasma concentrations of natriuretic propeptides in healthy young males. Clin Chem. 2012 Apr;58(4):789-92. doi: 10.1373/clinchem.2011.178921. Epub 2012 Jan 26. No abstract available.
PMID: 22282468BACKGROUNDArora P, Reingold J, Baggish A, Guanaga DP, Wu C, Ghorbani A, Song Y, Chen-Tournaux A, Khan AM, Tainsh LT, Buys ES, Williams JS, Heublein DM, Burnett JC, Semigran MJ, Bloch KD, Scherrer-Crosbie M, Newton-Cheh C, Kaplan LM, Wang TJ. Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc. 2015 Jan 16;4(1):e001265. doi: 10.1161/JAHA.114.001265.
PMID: 25595796BACKGROUNDBajaj NS, Gutierrez OM, Arora G, Judd SE, Patel N, Bennett A, Prabhu SD, Howard G, Howard VJ, Cushman M, Arora P. Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol. 2018 Jan 1;3(1):11-17. doi: 10.1001/jamacardio.2017.4207.
PMID: 29167879BACKGROUNDArora P, Wu C, Hamid T, Arora G, Agha O, Allen K, Tainsh RET, Hu D, Ryan RA, Domian IJ, Buys ES, Bloch DB, Prabhu SD, Bloch KD, Newton-Cheh C, Wang TJ. Acute Metabolic Influences on the Natriuretic Peptide System in Humans. J Am Coll Cardiol. 2016 Feb 23;67(7):804-812. doi: 10.1016/j.jacc.2015.11.049.
PMID: 26892417BACKGROUNDParcha V, Patel N, Gutierrez OM, Li P, Gamble KL, Musunuru K, Margulies KB, Cappola TP, Wang TJ, Arora G, Arora P. Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals. J Am Coll Cardiol. 2021 May 11;77(18):2291-2303. doi: 10.1016/j.jacc.2021.03.291.
PMID: 33958126RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Pankaj Arora
- Organization
- UNIVERSITY OF ALABAMA AT BIRMINGHAM
Study Officials
- PRINCIPAL INVESTIGATOR
Pankaj Arora, MD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Orlando M Gutierrez, MMSc
University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 6, 2019
First Posted
February 7, 2019
Study Start
April 1, 2019
Primary Completion
February 29, 2020
Study Completion
March 31, 2021
Last Updated
February 5, 2024
Results First Posted
August 31, 2021
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share